U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
144811144811Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's DiseaseCompletedNo Results AvailableParkinson's DiseaseDrug: pramipexolehttps://ClinicalTrials.gov/show/NCT00666653
1448121448123D Imaging of the Hip Using DXACompletedNo Results AvailableOsteoporosis|Low-energy Trauma FractureDevice: DXA scan of hip|Device: CT scan of hiphttps://ClinicalTrials.gov/show/NCT00666640
144813144813Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential EffectsActive, not recruitingNo Results AvailablePost-menopausal OsteoporosisDrug: Ibandronate|Drug: Risedronate|Drug: Alendronatehttps://ClinicalTrials.gov/show/NCT00666627
144814144814A Pilot Study to Examine Sleep and Fatigue in Pediatric Brain Tumor Patients Hospitalized for High Dose ChemotherapyCompletedNo Results AvailableSleep|FatigueOther: Sleep Environment Intervention|Other: Normal Hospital Environmenthttps://ClinicalTrials.gov/show/NCT00666614
144815144815Microdialysis and Pharmacokinetic Study of TR-701CompletedNo Results AvailableHealthyDrug: TR-700 (active moiety)|Drug: TR-701 (pro-drug)https://ClinicalTrials.gov/show/NCT00666601
144816144816Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid LeukemiaCompletedHas ResultsAdult Acute Monoblastic Leukemia (M5a)|Adult Acute Monocytic Leukemia (M5b)|Adult Acute Myeloblastic Leukemia With Maturation (M2)|Adult Acute Myeloblastic Leukemia Without Maturation (M1)|Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities|Adult Drug: idarubicin|Drug: cytarabine|Drug: bortezomib|Drug: etoposide|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00666588
144817144817A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional SleeplessnessCompletedNo Results AvailableTransient InsomniaDrug: Gabapentin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00666575
144818144818Green Tea Extract in Treating Patients With Nonmetastatic Bladder CancerTerminatedNo Results AvailableStage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder CancerDietary Supplement: defined green tea catechin extract|Drug: placebo|Procedure: therapeutic conventional surgery|Other: pharmacological study|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00666562
144819144819Research Tissue BankRecruitingNo Results AvailableMyelofibrosis|Idiopathic Myelofibrosis|Essential Thrombocythemia|Polycythemia Verahttps://ClinicalTrials.gov/show/NCT00666549
144820144820The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) MonotherapyCompletedHas ResultsHypertensionDrug: valsartan and amlodipine|Drug: valsartan and amlodipinehttps://ClinicalTrials.gov/show/NCT00666536
144821144821Effect of Phytalgic in Osteoarthritis (OA)CompletedNo Results AvailableOsteoarthritisDietary Supplement: phytalgic|Dietary Supplement: placebohttps://ClinicalTrials.gov/show/NCT00666523
144822144822Bronchospasm Associated With High Nitric OxideCompletedNo Results AvailableAsthma|Airway Hyperresponsivenesshttps://ClinicalTrials.gov/show/NCT00666510
144823144823Phase 2 Study of Azacitidine (Vidaza) vs MGCD0103 vs Combination in Elderly Subjects With Newly Diagnosed Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)TerminatedNo Results AvailableAcute Myeloid Leukemia (AML)|Myelodysplastic Syndrome (MDS)Drug: Azacitidine|Drug: MGCD0103|Drug: MGCD0103https://ClinicalTrials.gov/show/NCT00666497
144824144824Combination Chemotherapy in Treating Younger Patients With Hodgkin LymphomaCompletedNo Results AvailableLymphoma|NeurotoxicityDrug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: etoposide|Drug: prednisolone|Drug: procarbazine hydrochloride|Drug: vincristine sulfate|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00666484
144825144825Minimally Invasive Control of Epistaxis (MICE)TerminatedNo Results AvailableEpistaxisProcedure: MICE|Procedure: SPA ligationhttps://ClinicalTrials.gov/show/NCT00666471
14482614482618-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D)CompletedHas ResultsType 2 DiabetesDrug: saxagliptin|Drug: sitagliptinhttps://ClinicalTrials.gov/show/NCT00666458
144827144827Improved Diagnosis of Alzheimer's Disease Using the Synchronous Neural Interactionâ„¢ TestCompletedNo Results AvailableAlzheimer's Diseasehttps://ClinicalTrials.gov/show/NCT00666445
144828144828Bipolar and Schizophrenia Consortium for Parsing Intermediate PhenotypesActive, not recruitingNo Results AvailableSchizophrenia|BipolarOther: This is an observational study model that is family basedhttps://ClinicalTrials.gov/show/NCT00666432
144829144829Prevalence of Back Pain and Associated Risk Factors in 10-12 Year Old SchoolchildrenWithdrawnNo Results AvailableLow Back PainOther: Measurement, weight, and muscle strength testhttps://ClinicalTrials.gov/show/NCT00666419
144830144830Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia ACompletedHas ResultsHemophilia ADrug: Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM)|Drug: Recombinant Factor VIII (rAHF)https://ClinicalTrials.gov/show/NCT00666406
144831144831An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric PatientsWithdrawnNo Results AvailablePain, Postoperative|PediatricsDrug: fentanyl iontophoretic transdermal system (40mcg) No placebo|Drug: fentanyl iontophoretic transdermal system (40mcg)https://ClinicalTrials.gov/show/NCT00666393
144832144832A Study to Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in KenyaCompletedNo Results AvailableMalariaBiological: Plasmodium falciparum Malaria Protein 010 (FMP010)https://ClinicalTrials.gov/show/NCT00666380
144833144833Vitamin D as Treatment for Chronic Obstructive Pulmonary Disease (COPD)CompletedNo Results AvailableChronic Obstructive Pulmonary DiseaseDrug: D-cure|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00666367
144834144834Dose Response and Safety Study of Topical Methotrexate for the Treatment of Fingernail PsoriasisActive, not recruitingNo Results AvailableFingernail PsoriasisDrug: Methotrexate|Drug: Methotrexate|Drug: Methotrexatehttps://ClinicalTrials.gov/show/NCT00666354
144835144835Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) AllergensCompletedNo Results AvailableType I-AllergyDrug: placebo|Biological: rPhleum|Biological: rPhleum|Biological: rPhleum|Biological: rPhleumhttps://ClinicalTrials.gov/show/NCT00666341
144836144836Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE)CompletedHas ResultsHypertension|HemorrhageDrug: clevidipinehttps://ClinicalTrials.gov/show/NCT00666328
144837144837Harmonic FOCUS Versus Conventional Technique in Total Thyroidectomy for Benign Thyroid DiseaseCompletedNo Results AvailableBenign Thyroid Diseasehttps://ClinicalTrials.gov/show/NCT00666315
144838144838A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic DermatitisCompletedNo Results AvailableDermatitis, AtopicDrug: tacrolimus ointment|Drug: pimecrolimus creamhttps://ClinicalTrials.gov/show/NCT00666302
144839144839Familial Myeloproliferative DisordersRecruitingNo Results AvailablePolycythemia Vera|Essential Thrombocythemia|Idiopathic Myelofibrosishttps://ClinicalTrials.gov/show/NCT00666289
144840144840Drug Use Investigation Of Zyvox (Linezolid) (Regulatory Post Marketing Commitment Plan)CompletedHas ResultsStaphylococcal InfectionsDrug: linezolid (Zyvox)https://ClinicalTrials.gov/show/NCT00666276

* Görseller ve İçerik tekif hakkına sahip olabilir